Gradiant Corporation (035080.KQ) engages in diversified e-commerce and investment activities across multiple segments in South Korea, Vietnam, China and internationally. The company operates through its Holding Business; Industrial B2B E-Commerce Business; Bio Healthcare Business; and Other Business segments, focusing on life sciences and healthcare, environment and energy, and creative learning platform businesses. It offers EV charging services; organoids and venture capital funding for the biotech sector; advertising and logistics agency services; an online creative learning platform; procurement and distribution of pharmaceutical drugs and medical supplies to hospitals; development of oncology drugs; development, manufacture and commercialization of adhesive films for electronic devices such as smartphones; and supplies of MRO and industrial consumables goods through the internet; as well as investing, consulting, and freight transportation brokerage and agency activities. Founded in 1995 and headquartered in Seoul, South Korea, the company, formerly known as Interpark Co., Ltd., changed its name to Gradiant Corporation in February 2022 to reflect its strategic pivot toward science and technology-driven innovation. In recent developments, Gradiant Corporation announced the expiration of its equity buyback program on December 4, 2025, having repurchased 850,986 shares representing 6.22% of its capital for KRW 11,913.8 million, and reported earnings results for the third quarter and nine months ended September 30, 2025.